Bacillus Calmette‐Guérin infection after vaccination of human immunodeficiency virus‐infected children

S. Sauvion,C. Offredo,J. Gaudelus,J. Gaillard,F. Veber,S. Blanche
DOI: https://doi.org/10.1097/00006454-199312000-00006
1993-12-01
The Pediatric Infectious Disease Journal
Abstract:The use of Mycobacterium bovis/Bacillus Calmette-Guérin (BCG) to vaccinate against tuberculosis remains controversial. The development of tuberculosis in human immunodeficiency virus (HIV)-infected children demands specific evaluation of the risk/benefit ratio of BCG vaccination in this situation. In our institution 9 of 68 HIV-infected children vaccinated with BCG before the diagnosis of HIV infection was suspected developed vaccine-related complications: 7 of these children had a large satellite adenopathy with or without skin fistulae, whereas the other 2 had disseminated BCG infection beyond the satellite ganglion (involvement of the spleen and mesenteric and mediastinal lymph nodes in one case and the liver and lungs in the
What problem does this paper attempt to address?